United States Biotechnology & Medical Research

Asterias Biotherapeutics Inc (AST)

Track

The most recent insider trading activity at Asterias Biotherapeutics Inc. occurred on August 27, 2018. The company's President and CEO, Michael H. Mulroy, consistently executed monthly planned purchases of shares throughout 2018. Prior to this, significant buying activity was recorded in October 2017 by Broadwood Partners, L.P.
Ticker: AST Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned buy 27 Aug 2018
Value US$2,324,624.55 | Price 291.56 | Shares 12,820 (-1.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-08-29 2018-08-27 PP Planned purchase Mulroy Michael H.

President and CEO
12,820 -1.5%
291.56
US$2,324,625 		12,820 -1.5% 291.56 US$2,324,625
2018-07-27 2018-07-25 PP Planned purchase Mulroy Michael H.

President and CEO
8,259 -31.8%
444.00
US$1,063,129 		8,259 -31.8% 444.00 US$1,063,129
2018-06-27 2018-06-25 PP Planned purchase Mulroy Michael H.

President and CEO
41,419 +22.5%
361.88
US$4,306,874 		41,419 +22.5% 361.88 US$4,306,874
2018-05-31 2018-05-25 PP Planned purchase Mulroy Michael H.

President and CEO
3,153 +3.7%
1.59
US$5,000 		3,153 +3.7% 1.59 US$5,000
2018-04-27 2018-04-25 PP Planned purchase Mulroy Michael H.

President and CEO
3,752 +4.6%
1.33
US$4,990 		3,752 +4.6% 1.33 US$4,990
2018-03-28 2018-03-26 PP Planned purchase Mulroy Michael H.

President and CEO
2,839 +3.6%
1.76
US$4,997 		2,839 +3.6% 1.76 US$4,997
2018-02-28 2018-02-26 PP Planned purchase Mulroy Michael H.

President and CEO
2,255 +22.7%
2.22
US$5,000 		2,255 +22.7% 2.22 US$5,000
2018-01-26 2018-01-25 PP Planned purchase Mulroy Michael H.

President and CEO
2,134 +27.4%
2.34
US$5,000 		2,134 +27.4% 2.34 US$5,000
2017-12-28 2017-12-26 PP Planned purchase Mulroy Michael H.

President and CEO
2,247 +40.5%
2.22
US$4,988 		2,247 +40.5% 2.22 US$4,988
2017-11-29 2017-11-27 PP Planned purchase Mulroy Michael H.

President and CEO
2,076 +59.7%
2.41
US$5,003 		2,076 +59.7% 2.41 US$5,003
2017-10-27 2017-10-25 PP Planned purchase Mulroy Michael H.

President and CEO
1,939 +126.2%
2.55
US$4,944 		1,939 +126.2% 2.55 US$4,944
2017-10-18 2017-10-16 B Purchase BROADWOOD PARTNERS, L.P.
0
0.00
US$0 		0 0.00 US$0
2017-10-18 2017-10-16 B Purchase BROADWOOD PARTNERS, L.P.
1,592,308 +43.0%
2.60
US$4,140,001 		1,592,308 +43.0% 2.60 US$4,140,001
2017-09-27 2017-09-25 PP Planned purchase Mulroy Michael H.

President and CEO
1,537 +inf%
3.25
US$4,997 		1,537 +inf% 3.25 US$4,997
2017-01-11 2017-01-09 PlS Planned sale Spink Katharine E.

Chief Operating Officer
4,781 -100.0%
4.60
US$22,007 		4,781 -100.0% 4.60 US$22,007
2017-01-11 2017-01-09 PlS Planned sale Wirth Edward

Chief Medical Officer
3,415 -100.0%
4.60
US$15,719 		3,415 -100.0% 4.60 US$15,719
2017-01-06 2016-12-27 PlS Planned sale Spink Katharine E.

Chief Operating Officer
2,500 -100.0%
5.00
US$12,500 		2,500 -100.0% 5.00 US$12,500
2017-01-06 2016-12-27 PlS Planned sale Wirth Edward

Chief Medical Officer
2,500 -100.0%
5.00
US$12,500 		2,500 -100.0% 5.00 US$12,500
2016-11-28 2016-11-23 PlS Planned sale Spink Katharine E.

Chief Operating Officer

Officer
2,500 -100.0%
5.41
US$13,525 		2,500 -100.0% 5.41 US$13,525
2016-11-21 2016-11-17 PlS Planned sale Wirth Edward

Chief Medical Officer

Officer
2,500 -100.0%
5.00
US$12,500 		2,500 -100.0% 5.00 US$12,500
2016-11-21 2016-11-17 PlS Planned sale Spink Katharine E.

Chief Operating Officer

Officer
2,500 -100.0%
5.00
US$12,500 		2,500 -100.0% 5.00 US$12,500
2016-10-11 2016-10-06 PlS Planned sale Spink Katharine E.

Chief Operating Officer

Officer
4,781 -100.0%
4.11
US$19,635 		4,781 -100.0% 4.11 US$19,635
2016-10-11 2016-10-06 PlS Planned sale Wirth Edward

Chief Medical Officer

Officer
3,415 -100.0%
4.12
US$14,084 		3,415 -100.0% 4.12 US$14,084
2016-09-12 2016-09-09 PlS Planned sale Wirth Edward

Chief Medical Officer

Officer
3,179 -100.0%
3.58
US$11,384 		3,179 -100.0% 3.58 US$11,384
2016-09-12 2016-09-09 PlS Planned sale Spink Katharine E.

Chief Operating Officer

Officer
9,608 -100.0%
3.54
US$33,989 		9,608 -100.0% 3.54 US$33,989
2016-09-12 2016-09-08 PlS Planned sale Wirth Edward

Chief Medical Officer

Officer
11,581 -78.5%
3.50
US$40,534 		11,581 -78.5% 3.50 US$40,534
2016-09-12 2016-09-08 PlS Planned sale Spink Katharine E.

Chief Operating Officer

Officer
9,728 -50.3%
3.50
US$34,048 		9,728 -50.3% 3.50 US$34,048
2016-07-01 2016-06-30 B Purchase Cartt Stephen LaHue

President and CEO

Executive Director
10,000 +4.0%
2.40
US$23,977 		10,000 +4.0% 2.40 US$23,977
2016-07-01 2016-06-29 B Purchase LeBuhn Richard T. Non-Executive Director
5,000 +25.0%
2.38
US$11,900 		5,000 +25.0% 2.38 US$11,900
2016-06-13 2016-06-10 B Purchase Cartt Stephen LaHue

President and CEO

Executive Director
50,000 +25.0%
2.93
US$146,530 		50,000 +25.0% 2.93 US$146,530
2016-06-10 2016-06-09 B Purchase KINGSLEY ALFRED D Non-Executive Director
4,000 +80.0%
2.93
US$11,720 		4,000 +80.0% 2.93 US$11,720
2016-05-17 2016-05-13 B Purchase LeBuhn Richard T. Non-Executive Director
15,000 +300.0%
3.39
US$50,850 		15,000 +300.0% 3.39 US$50,850
2016-05-17 2016-05-13 B Purchase BAILEY DON M Non-Executive Director
88,235 +inf%
3.39
US$299,117 		88,235 +inf% 3.39 US$299,117
2016-05-17 2016-05-13 B Purchase RICCIARDI NATALE S Non-Executive Director
14,706 +294.1%
3.39
US$49,853 		14,706 +294.1% 3.39 US$49,853
2016-05-13 2016-05-13 B Purchase BROADWOOD PARTNERS LP
0
0.00
US$0 		0 0.00 US$0
2016-05-13 2016-05-13 B Purchase BROADWOOD PARTNERS LP
2,058,823
0.00
US$0 		2,058,823 0.00 US$0
2015-06-26 2015-06-25 B Purchase LeBuhn Richard T. Non-Executive Director
5,000 +inf%
4.41
US$22,062 		5,000 +inf% 4.41 US$22,062
2015-06-26 2015-06-25 B Purchase Arno Andrew Non-Executive Director
5,000 +inf%
4.32
US$21,600 		5,000 +inf% 4.32 US$21,600
2015-06-26 2015-06-25 B Purchase RICCIARDI NATALE S Non-Executive Director
5,000 +inf%
4.40
US$21,975 		5,000 +inf% 4.40 US$21,975
2015-06-26 2015-06-25 B Purchase KINGSLEY ALFRED D Non-Executive Director
5,000 +inf%
4.32
US$21,577 		5,000 +inf% 4.32 US$21,577
2015-02-11 2015-02-09 B Purchase LICHTINGER PEDRO

Chief Executive Officer

Executive Director
128,205 +32.1%
3.90
US$500,000 		128,205 +32.1% 3.90 US$500,000
2014-10-06 2014-10-01 B Purchase Scarsdale Equities LLC

Former 10% Owner
50,000 +6.0%
5.97
US$298,355 		50,000 +6.0% 5.97 US$298,355
2014-10-06 2014-09-29 B Purchase Scarsdale Equities LLC

Former 10% Owner
10,000 +1.2%
5.73
US$57,260 		10,000 +1.2% 5.73 US$57,260
2014-09-25 2014-09-24 B Purchase Scarsdale Equities LLC Large shareholder
10,000 +1.2%
5.35
US$53,536 		10,000 +1.2% 5.35 US$53,536
2014-09-25 2014-09-23 B Purchase Scarsdale Equities LLC Large shareholder
15,000 +1.9%
4.58
US$68,660 		15,000 +1.9% 4.58 US$68,660
2014-09-08 2014-09-05 B Purchase Scarsdale Equities LLC Large shareholder
30,000 +3.9%
5.48
US$164,346 		30,000 +3.9% 5.48 US$164,346
2014-09-08 2014-09-04 B Purchase Scarsdale Equities LLC Large shareholder
70,000 +9.9%
4.00
US$279,797 		70,000 +9.9% 4.00 US$279,797
Explore more

More insider trading research around Asterias Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America